<DOC>
	<DOCNO>NCT01348425</DOCNO>
	<brief_summary>This randomize , post-market clinical study intend evaluate delivery deployment longer Zilver PTX stent ( ≥ 100 mm ) compare short Zilver PTX stent ( ≤80 mm ) treatment lesion above-the-knee femoropopliteal artery .</brief_summary>
	<brief_title>Zilver PTX Drug-Eluting Peripheral Stent Study</brief_title>
	<detailed_description />
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<criteria>One de novo restenosed artherosclerotic lesion &gt; 50 % diameter stenosis Reference vessel diameter 4 9 mm Rutherford category ≥ 2 Resting ankle brachial index &lt; 0.9 Prior stent study vessel Significant stenosis ( &gt; 50 % ) occlusion inflow tract successfully treat study procedure Lacks least one patent runoff vessel Lesions require atherectomy , cut balloon , cryoplasty balloon , advanced device facilitate stent delivery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>PAD</keyword>
</DOC>